Linnaeus Therapeutics Funding: $72M Raised, Series B (2025)
Linnaeus Therapeutics is based in Haddonfield, NJ. It has raised $72M in total funding. Latest round: Series B.
Linnaeus Therapeutics funding overview
Linnaeus Therapeutics is based in Haddonfield, NJ. Linnaeus Therapeutics has raised $72M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2025. The round record for Linnaeus Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include National Cancer Institute, ARPA-H, University of Pennsylvania. 3 distinct backers are named across the disclosed rounds.
Linnaeus Therapeutics at a glance
Total raised
$72M
Latest round
Series B
Latest round date
January 2025
Headquarters
Haddonfield, NJ
Notable investors
National Cancer Institute, ARPA-H, University of Pennsylvania
Frequently asked about Linnaeus Therapeutics funding
How much has Linnaeus Therapeutics raised?
Linnaeus Therapeutics has raised $72M in total disclosed funding across the rounds on record.
Who has invested in Linnaeus Therapeutics?
National Cancer Institute, ARPA-H, University of Pennsylvania are named among the investors backing Linnaeus Therapeutics.
What was the latest Linnaeus Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2025.
Where is Linnaeus Therapeutics based?
Linnaeus Therapeutics is based in Haddonfield, NJ.
When did Linnaeus Therapeutics last raise?
The last disclosed Linnaeus Therapeutics round closed in January 2025 at Series B.
We update the Linnaeus Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Haddonfield and their backers are listed below.
